ASE Amends Ainos 13D on Notes & Reverse Split

2026-04-15SEC Filing SCHEDULE 13D/A (0000950103-26-005722)

ASE Technology Holding Co., Ltd. (ASX) and its subsidiary ASE Test Taiwan filed an amendment to their Schedule 13D regarding Ainos, Inc. (AIMD). The filing reflects a beneficial ownership of 667,085 shares, representing approximately 8.4% of the class. This position includes 11,777 shares held directly and 655,308 shares underlying convertible instruments and warrants. Specifically, the holdings involve a 2023 Convertible Promissory Note (amended March 2025) and a 2024 Convertible Note, both bearing 6% compound interest and maturing in 2027. The 2023 note is convertible at prices between $22.50 and $37.50, while the 2024 note and an associated warrant for 100,000 shares have a conversion/exercise price of $22.50. These figures account for a one-for-five reverse stock split effective June 30, 2025. Additionally, ASE Test Taiwan is party to a Voting Agreement with Ainos KY, agreeing to vote its shares as directed by Ainos KY and adhering to certain transfer restrictions through May 2026. the primary purpose of the investment remains financial in nature.